Status:
COMPLETED
Skin Denervation in Systemic Lupus Erythematosus
Lead Sponsor:
National Taiwan University Hospital
Conditions:
Systemic Lupus Erythematosus
Eligibility:
All Genders
18-80 years
Phase:
PHASE1
Brief Summary
To address the issues of skin denervation and its clinical and pathological correlations in systemic lupus erythematosus
Detailed Description
To address the issues of skin denervation and its clinical and pathological correlations in lupus, we will study a systemic lupus erythematosus (SLE) cohort by evaluating the extent of cutaneous inner...
Eligibility Criteria
Inclusion
- Diagnosis of systemic lupus erythematosus based on the consensus criteria
Exclusion
- Conditions known to be associated with peripheral neuropathy, such as diabetes, uremia, alcoholism, and the administration of potentially neurotoxic agents, such as alkylating agents, methotrexate, cyclosporine, and antibiotics.
Key Trial Info
Start Date :
April 1 2002
Trial Type :
INTERVENTIONAL
End Date :
March 1 2004
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT00155532
Start Date
April 1 2002
End Date
March 1 2004
Last Update
September 12 2005
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Departments of Neurology, National Taiwan University Hospital
Taipei, Taiwan